Oculis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oculis and other ETFs, options, and stocks.About OCS
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
OCS Key Statistics
Stock Snapshot
With a market cap of 694.11M, Oculis(OCS) trades at $12.07. The stock has a price-to-earnings ratio of -5.64.
On 2026-08-05, Oculis(OCS) stock moved within a range of $11.87 to $12.42. With shares now at $12.07, the stock is trading +1.7% above its intraday low and -2.8% below the session's peak.
Trading volume for Oculis(OCS) stock has reached 579.27K, versus its average volume of 349.28K.
The stock's 52-week range extends from a low of $10.52 to a high of $34.48.
The stock's 52-week range extends from a low of $10.52 to a high of $34.48.
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.